Form Type: 4

SEC EDGAR Link
Accession Number:0001127602-21-012790
Date:2021-02-01
Issuer: CVS HEALTH CORP (CVS)
Original Submission Date:

Reporting Person:

MORIARTY THOMAS M
ONE CVS DRIVE
WOONSOCKET, RI 02895

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-02-01 A 124,048 a $0.00 124,048 direct
COMMON STOCK 2021-04-01 F 61,095 d $74.30 62,953 direct
COMMON STOCK 2021-04-01 F 2,350 d $74.30 65,373 direct
COMMON STOCK 2021-02-01 0 $0.00 18,226 indirect
COMMON STOCK (RESTRICTED) 2021-02-01 0 $0.00 8,008 direct
STOCK UNIT 2021-02-01 0 $0.00 45,455 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION 74.3 2021-04-01 deemed execution date A 155,495 (a) 2022-04-01 2031-04-01 common stock 155,495 $74.30 155,495 direct
STOCK OPTION 102.26 2021-02-01 deemed execution date 0 ( ) 2016-04-01 2022-04-01 common stock 51,361 $102.26 51,361 direct
STOCK OPTION 104.82 2021-02-01 deemed execution date 0 ( ) 2017-04-01 2023-04-01 common stock 71,696 $104.82 71,696 direct
STOCK OPTION 78.05 2021-02-01 deemed execution date 0 ( ) 2018-04-03 2024-04-03 common stock 125,224 $78.05 125,224 direct
STOCK OPTION 62.21 2021-02-01 deemed execution date 0 ( ) 2019-04-01 2025-04-01 common stock 145,959 $62.21 145,959 direct
STOCK OPTION 54.19 2021-02-01 deemed execution date 0 ( ) 2020-04-01 2029-04-01 common stock 202,007 $54.19 202,007 direct
STOCK OPTION 58.34 2021-02-01 deemed execution date 0 ( ) 2021-04-01 2030-04-01 common stock 197,116 $58.34 197,116 direct
Footnotes
IDfootnote
f1 represents shares earned by the reporting person pursuant to certain performance stock units (the "psus"), which were granted to the reporting person under the issuer's 2017 incentive compensation plan on february 1, 2021. the psus were earned based on the attainment of certain performance metrics, which performance metrics were certified by the management and planning committee of the board of directors of the issuer on february 1, 2021. the psus vested and settled on april 1, 2021.
f2 surrender of shares in payment of taxes due upon the vesting and settlement of the psus on april 1, 2021.
f3 surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on april 1, 2021.
f4 option becomes exercisable in four equal installments, commencing 4/1/2022.
f5 option became exercisable in four equal annual installments, commencing 4/1/2016.
f6 option became exercisable in four equal annual installments, commencing 4/1/2017.
f7 option became exercisable in four equal annual installments, commencing 4/3/2018.
f8 option became exercisable in four equal annual installments, commencing 4/1/2019.
f9 option became exercisable in four equal annual installments, commencing 4/1/2020.
f10 the number of shares subject to the option were calculated using a 30-day average price.
f11 option becomes exercisable in four equal annual installments, commencing 4/1/2021.
WhaleWisdom Logo

Elevate your investments